Details For Selected Brain Tumor Treatment
Sponsored By
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV)
Please Click On The Above Banner For More Details
Braintumor Website

Back to New Treatments List Back to New Treatments List

Treatment Name: Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Phase: Phase 3
Treatment ID#: 1924        
Age Group: Adults Only
Min Karnofsky Score: 70: Cares for self, unable to perform normal activity or to do active work
Conditions: Prior Surgery is Allowed
Prior Radiation is Sometimes Allowed
Prior Chemotherapy is Sometimes Allowed
IF you are interested in this trial, contact them as soon as possible, as there is a strict window of opportunity to join. Some of our members missed by a few days.
Last Updated: 04/29/2012
Tumor Types: Glioblastoma Multiforme
Comments: See Novocure for more information on this device!
Treatment Type: Chemotherapy
Contact: Andrew B. Lassman MD
Columbia University Medical Center
Contact: Daniel Otap

New York, NY 10032 USA
  • Last updated refers to the date when our listing for each treatment was last updated.
  • ID is a combination of our internal ID and the official ID for the trial, if any.
  • Min Karnofsky is a general guide to how well you have to function to use this treatment

Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book

Copyright (c) 1993 - 2014 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557

Website Design By
World Wide Websites